Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1093/labmed/lmab032

http://scihub22266oqcxt.onion/10.1093/labmed/lmab032
suck pdf from google scholar
33928380!8600477!33928380
unlimited free pdf from europmc33928380    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33928380      Lab+Med 2021 ; 52 (5): 493-498
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19 #MMPMID33928380
  • Lo Sasso B; Gambino CM; Scichilone N; Giglio RV; Bivona G; Scazzone C; Muratore R; Milano S; Barbagallo M; Agnello L; Ciaccio M
  • Lab Med 2021[Sep]; 52 (5): 493-498 PMID33928380show ga
  • OBJECTIVE: The aim of the study was to assess the role of midregional proadrenomedullin (MR-proADM) in patients with COVID-19. METHODS: We included 110 patients hospitalized for COVID-19. Biochemical biomarkers, including MR-proADM, were measured at admission. The association of plasma MR-proADM levels with COVID-19 severity, defined as a requirement for mechanical ventilation or in-hospital mortality, was evaluated. RESULTS: Patients showed increased levels of MR-proADM. In addition, MR-proADM was higher in patients who died during hospitalization than in patients who survived (median, 2.59 nmol/L; interquartile range, 2.3-2.95 vs median, 0.82 nmol/L; interquartile range, 0.57-1.03; P <.0001). Receiver operating characteristic curve analysis showed good accuracy of MR-proADM for predicting mortality. A MR-proADM value of 1.73 nmol/L was established as the best cutoff value, with 90% sensitivity and 95% specificity (P <.0001). CONCLUSION: We found that MR-proADM could represent a prognostic biomarker of COVID-19.
  • |Adrenomedullin/*blood[MESH]
  • |Aged[MESH]
  • |Alanine Transaminase/blood[MESH]
  • |Aspartate Aminotransferases/blood[MESH]
  • |Biomarkers/blood[MESH]
  • |C-Reactive Protein/metabolism[MESH]
  • |COVID-19/blood/*diagnosis/mortality/virology[MESH]
  • |Comorbidity[MESH]
  • |Female[MESH]
  • |Humans[MESH]
  • |Hypertension/blood/*diagnosis/mortality/virology[MESH]
  • |Interleukin-6/blood[MESH]
  • |Lung Diseases/blood/*diagnosis/mortality/virology[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Patient Selection[MESH]
  • |Prognosis[MESH]
  • |Protein Precursors/*blood[MESH]
  • |Retrospective Studies[MESH]
  • |SARS-CoV-2[MESH]
  • |Severity of Illness Index[MESH]
  • |Survival Analysis[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box